Abbott to distribute Novo Nordisk's semaglutide second brand Extensior in India
The companies announced that Abbott will commercialise the drug in India while Novo Nordisk supplies the molecule, which is globally known as Ozempic.
FTA will be one of the biggest game changers: Santosh Iyer, MD and CEO, Mercedes-Benz India
With clearer investment protection frameworks for European companies operating in India, the agreements could accelerate capital expenditure (capex) inflows and sustain growth momentum, Iyer said
The Reading List: February 27, 2026
Our research and opinion teams have curated a selection of articles and social media gems from the world of economy, business and finance for your weekend read
GSK study flags low Shingles awareness among older Indians despite rising risk
Shingles, caused by the reactivation of the varicella‑zoster virus (VZV), typically presents as a painful rash with blisters and can lead to long‑lasting nerve pain known as post‑herpetic neuralgia (PHN). Age‑related immune decline makes adults over 50—particularly those with chronic illnesses—significantly more vulnerable.
Control intensive products maker Sedemac Mechatronics to launch Rs 1,087 crore IPO on March 4, check price band and other details
Sedemac Mechatronics IPO | The initial public offering is entirely an offer for sale of 80.43 lakh equity shares, with no fresh issue component.
Credent Global Finance raises Rs 30 crore capital through QIP for business growth
Institutional investors participated in QIP, reinforcing investor confidence in Credent's evolving financial services platform and long-term growth strategy.
Accord Transformer, Mobilise App Lab IPOs attract robust demand but Kiaasa Retail sees muted response on final day
Accord Transformer and Switchgear, Mobilise App Lab, and Kiaasa Retail will finalise IPO share allotment by February 26, while their shares will be available for trading on the bourses on March 2.
Cipla’s Yurpeak gains ground beyond metros as GLP‑1 market accelerates
Strong uptake is visible across Mumbai, Bengaluru, Delhi, Chennai, Hyderabad, Indore and Pune, as well as smaller but fast‑growing centres such as Cannanore, Vijayawada, Aurangabad, Surat, Faizabad and Mangalore—locations where prescriber activation and distribution density are translating into early conversions.
OPINION | CSR at a Crossroads: Building systems, not just projects
India’s growing CSR capital can create lasting national impact by shifting from short-term projects to systemic investments aligned with government priorities and strong leadership
TVS, Bajaj and Hero race ahead in electric two-wheeler market; Honda, Suzuki still to rev up
TVS Motor Company, Bajaj Auto and Hero MotoCorp together command nearly 60% of the domestic E2W market, which has grown to approximately 1.23 lakh units a month
Omnitech Engineering raises Rs 175 crore via anchor book ahead of Rs 583-crore IPO
Omnitech Engineering IPO | The company is raising Rs 418 crore by issuing fresh shares, while promoter Udaykumar Arunkumar Parekh will be selling shares worth Rs 165 crore via offer-for-sale.
Manilam Industries India IPO closes with 5.89 times subscription, listing likely scheduled on February 27
Manilam Industries IPO | The company is raising Rs 40 crore via public issue of 57.9 lakh shares, which comprised of fresh issue of 46.98 lakh shares, and an offer-for-sale of 10.92 lakh shares.
Eris Lifesciences partners with Natco Pharma to launch semaglutide in India
The collaboration follows Natco’s recent approval from the Central Drugs Standard Control Organisation (CDSCO) to manufacture generic semaglutide, setting up a planned launch in March 2026.
Reva Diamonds raises Rs 171 crore from 16 anchor investors, Rs 380-crore IPO to open for public on February 24
PNGS Reva Diamond Jewellery IPO | The company has finalised allocation of 44.19 lakh equity shares to anchor investors at the upper price band.
Manilam Industries India IPO fully subscribed on day 2, offer closes on February 24
Manilam Industries IPO | The Uttar Pradesh-based company is raising nearly Rs 40 crore via initial public offering of 57.9 lakh shares at the upper end of price band of Rs 65-69 per share.
Accord Transformer, Mobilise App Lab IPOs see healthy subscription on day 1 but Kiaasa Retail offer undersubscribed
Accord Transformer, Mobilise App Lab, and Kiaasa Retail IPOs will remain open for subscription till February 25.
Biocon ramps up biosimilar push, eyes global semaglutide rollout as capex eases
As Shreehas Tambe readies to take charge of the unified Biocon Group following the integration of Biocon Biologics, the company is entering what he calls a “capacity‑rich, demand‑heavy” phase—one where margins improve as capital and R&D intensity taper off.
Torrent Group enters diagnostics segment with India’s largest reference lab in Navi Mumbai
The 100,000‑sq‑ft lab spans 15 diagnostic disciplines and more than 3,500 test modalities, handling everything from molecular diagnostics and genomics to digital pathology, microbiology and transplant‑related testing.
CDSCO to get 1,500‑member scientific cadre, will speed up drug approvals
The government has agreed ‘in principle’ to the move and a proposal would be send for approval by March, DGCI Rajeev Singh Raghuvanshi has said
Will “remove rot of cough‑syrup manufacturing” by next production season: Central drug controller
The regulator has already inspected around 1,150 facilities, or 90% of cough syrup making plants, physically visiting plants and taking enforcement action wherever serious lapses were found.
IPO Action: Investors to see 9 public issues worth Rs 4,400 crore next week, 4 firms lined up for listing
Upcoming IPOs | The participants will see total five IPOs opening for subscription on the first day of next week i.e. February 23 including Clean Max Enviro Energy Solutions, and Shree Ram Twistex from the mainboard segment
Yashhtej Industries Rs 89-crore IPO closes with 1.35 times subscription, listing scheduled on February 25
Yashhtej Industries IPO | The company is raising Rs 88.88 crore via initial public offering (IPO) of 80.79 lakh shares at a price of Rs 110 per share.
Clean Max Enviro Energy raises Rs 921 crore via anchor book ahead of Rs 3,100-crore IPO
Clean Max Enviro Energy Solutions IPO | | The company is raising Rs 1,200 crore by issuing fresh shares, while promoters and investors will be selling shares worth Rs 1,900 crore via offer-for-sale.
Everstone‑backed Integris Medtech gets SEBI nod for IPO
The Everstone Capital–backed company, India’s second‑largest home‑grown diversified medtech platform by FY25 operating revenue, plans to raise up to Rs 925 crore through a fresh issue of shares, alongside an offer for sale of 21.67 million shares from existing investors and founders.
Integris Medtech, Anjali Labtech, APPL Containers, Alpine Texworld IPOs get approval from SEBI
SEBI has issued observations on the draft papers of Integris Medtech on February 13, and Anjali Labtech on February 17, while the observations issued by the regulator on draft document of APPL Containers, and Alpine Texworld on February 20.
